Search Results - Durrant, Lindy

Lindy Durrant

Lindy Durrant is a British immunologist who is Professor of Cancer Immunotherapy at the University of Nottingham and Chief Scientific Officer and Chief Executive Officer of the UK AIM listed biotech company Scancell Ltd. Durrant's work focusses on harnessing the immune system to treat cancer and infectious disease. Across her career Durrant has developed a panel of monoclonal antibodies which recognise tumour associated glycans, pioneered novel antibody engineering technology to enhance the avidity of monoclonal antibodies as well as developed a number of different cancer vaccine platforms to target cancers such as melanoma, triple negative breast cancer, head and neck cancer amongst others. Provided by Wikipedia
  • Showing 1 - 14 results of 14
Refine Results
  1. 1
    Ensemble learning of colorectal cancer survival rates

    Ensemble learning of colorectal cancer survival rates by Roadknight, Chris, Aickelin, Uwe, Scholefield, John, Durrant, Lindy

    Published 2013
    Get full text
  2. 2
    Wavelet feature extraction and genetic algorithm for biomarker detection in colorectal cancer data

    Wavelet feature extraction and genetic algorithm for biomarker detection in colorectal cancer data by Liu, Yihui, Aickelin, Uwe, Feyereisl, Jan, Durrant, Lindy G

    Published 2013
    Get full text
  3. 3
    Supervised learning and anti-learning of colorectal cancer classes and survival rates from cellular biology parameters

    Supervised learning and anti-learning of colorectal cancer classes and survival rates from cellular biology parameters by Roadknight, Chris, Aickelin, Uwe, Qiu, Guoping, Scholefield, John, Durrant, Lindy

    Published 2012
    Get full text
  4. 4
    An ensemble of machine learning and anti-learning methods for predicting tumour patient survival rates

    An ensemble of machine learning and anti-learning methods for predicting tumour patient survival rates by Roadknight, Chris, Suryanarayanan, Durga, Aickelin, Uwe, Scholefield, John, Durrant, Lindy

    Published 2015
    Get full text
  5. 5
    Biomarker clustering of colorectal cancer data to complement clinical classification

    Biomarker clustering of colorectal cancer data to complement clinical classification by Roadknight, Chris, Aickelin, Uwe, Ladas, Alex, Soria, Daniele, Scholefield, John, Durrant, Lindy

    Published 2012
    Get full text
  6. 6
    Susceptibility to SARS-CoV-2 omicron following ChAdOx1 nCoV-19 and BNT162b2 versus CoronaVac vaccination

    Susceptibility to SARS-CoV-2 omicron following ChAdOx1 nCoV-19 and BNT162b2 versus CoronaVac vaccination by Chua, Jia Xin, Durrant, Lindy Gillian, Chok, Yin Ling, Lai, Oi Ming

    Published 2022
    Get full text
  7. 7
    Total loss of MHC class I is an independent indicator of good prognosis in breast cancer

    Total loss of MHC class I is an independent indicator of good prognosis in breast cancer by Madjd, Zahra, Spendlove, Ian, Pinder, Sarah E., Ellis, Ian O., Durrant, Lindy G.

    Published 2005
    Get full text
  8. 8
    SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors

    SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors by Xue, Wei, Brentville, Victoria A., Symonds, Peter, Cook, Katherine, Yagita, Hideo, Metheringham, Rachael L., Durrant, Lindy

    Published 2016
    Get full text
  9. 9
    Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla

    Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla by Storr, Sarah J., Zaitoun, Abed M., Arora, Arvind, Durrant, Lindy G., Lobo, Dileep N., Madhusudan, Srinivasan, Martin, Stewart G.

    Published 2012
    Get full text
  10. 10
    SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade

    SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade by Xue, Wei, Metheringham, Rachael L., Brentville, Victoria A., Gunn, Barbara, Symonds, Peter, Yagita, Hideo, Ramage, Judith M., Durrant, Lindy

    Published 2016
    Get full text
  11. 11
    Citrullinated vimentin presented on MHC-II in tumor cells is a target for CD4+ T-cell-mediated antitumor immunity

    Citrullinated vimentin presented on MHC-II in tumor cells is a target for CD4+ T-cell-mediated antitumor immunity by Brentville, Victoria A., Metheringham, Rachael L., Gunn, Barbara, Symonds, Peter, Daniels, Ian, Gijon, Mohamed, Cook, Katherine, Xue, Wei, Durrant, Lindy

    Published 2016
    Get full text
  12. 12
    Citrullinated α-enolase is an effective target for anti-cancer immunity

    Citrullinated α-enolase is an effective target for anti-cancer immunity by Cook, Katherine, Daniels, Ian, Symonds, Peter, Pitt, Tracy, Gijon, Mohamed, Xue, Wei, Metheringham, Rachael L., Durrant, Lindy, Brentville, Victoria A.

    Published 2018
    Get full text
  13. 13
    High mobility group protein B1 is a predictor of poor survival in ovarian cancer

    High mobility group protein B1 is a predictor of poor survival in ovarian cancer by Machado, Lee R, Moseley, Paul M., Moss, Robert, Deen, Suha, Nolan, Christopher C., Spendlove, Ian, Ramage, Judith M., Chan, Stephen Y.T., Durrant, Lindy

    Published 2017
    Get full text
  14. 14
    Targeting gp100 and TRP-2 with a DNA vaccine: incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial

    Targeting gp100 and TRP-2 with a DNA vaccine: incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical... by Patel, Poulam M., Ottensmeier, Christian H., Mulatero, Clive, Lorigan, Paul, Plummer, Ruth, Pandha, Hardev S., Elsheikh, Somaia, Hadjimichael, Efthymios, Villasanti, Naty, Cunnell, Michelle, Metheringham, Rachael L., Brentville, Victoria A., Machado, Lee, Daniels, Ian, Gijon, Mohamed, Hannaman, Drew, Durrant, Lindy

    Published 2018
    Get full text

Search Tools: